Contact
Please use this form to send email to PR contact of this press release:
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia
TO:
Please use this form to send email to PR contact of this press release:
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia
TO: